Details for New Drug Application (NDA): 072399
✉ Email this page to a colleague
NDA 072399 describes TRIMETH/SULFA, which is a drug marketed by Alpharma Us Pharms and Naska and is included in three NDAs. Additional details are available on the TRIMETH/SULFA profile page.
The generic ingredient in TRIMETH/SULFA is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
The generic ingredient in TRIMETH/SULFA is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
Summary for 072399
| Tradename: | TRIMETH/SULFA |
| Applicant: | Naska |
| Ingredient: | sulfamethoxazole; trimethoprim |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 200MG/5ML;40MG/5ML | ||||
| Approval Date: | May 23, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
